← Browse by Condition
Medical Condition

melanoma cutaneous malignant

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3

ClinicalMetric aggregates all active clinical trials for melanoma cutaneous malignant from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT06743126 Phase 3
Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

Enrollment
360 pts
Location
United States, Canad...
Sponsor
Immatics US, Inc.
View Trial →